The document discusses ascorbic acid (vitamin C), corticosteroids (hydrocortisone), and thiamine and their potential roles in treating sepsis both individually and in combination. It notes that sepsis patients often have low vitamin C levels and outlines vitamin C's antioxidant and anti-inflammatory properties. It describes trials testing high-dose hydrocortisone in sepsis and notes risks of high doses. The document discusses thiamine deficiency in sepsis and trials of thiamine supplementation. It summarizes a study showing reduced mortality with combination hydrocortisone, vitamin C and thiamine (HAT) therapy in sepsis and notes ongoing randomized controlled trials are testing HAT therapy in severe sepsis and se